|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:age
|
9 to 45 years
|
|
gptkbp:approvalYear
|
2014
|
|
gptkbp:approvedBy
|
gptkb:United_States
gptkb:FDA
|
|
gptkbp:ATCCode
|
gptkb:J07BM03
|
|
gptkbp:contains
|
gptkb:L-histidine
gptkb:polysorbate_80
sodium chloride
borax
aluminum adjuvant
recombinant L1 proteins
|
|
gptkbp:dosingSchedule
|
2 or 3 doses
|
|
gptkbp:form
|
suspension for injection
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
GARDASIL 9
|
|
gptkbp:indication
|
anal cancer prevention
cervical cancer prevention
genital warts prevention
vaginal cancer prevention
vulvar cancer prevention
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Merck_&_Co.
|
|
gptkbp:marketedIn
|
gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:United_States
|
|
gptkbp:notRecommendedFor
|
treatment of cervical cancer
treatment of existing HPV infection
|
|
gptkbp:pregnancyCategory
|
B
|
|
gptkbp:preservativeFree
|
yes
|
|
gptkbp:protectedBy
|
HPV types 11
HPV types 16
HPV types 18
HPV types 31
HPV types 33
HPV types 45
HPV types 52
HPV types 58
HPV types 6
|
|
gptkbp:replacedBy
|
gptkb:Gardasil
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:sideEffect
|
fever
nausea
dizziness
headache
injection site pain
|
|
gptkbp:storage
|
2-8°C
|
|
gptkbp:usedFor
|
prevention of HPV infection
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
yes
|
|
gptkbp:bfsParent
|
gptkb:MRK
|
|
gptkbp:bfsLayer
|
5
|